Welcome to our dedicated page for Xcel Brands SEC filings (Ticker: XELB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Xcel Brands� filings tell the story behind every royalty check and retail partnership. When licensing revenue shifts between Isaac Mizrahi and Judith Ripka, it shows up in the Management Discussion of the Xcel Brands annual report 10-K simplified. If you track brand health through omnichannel sell-through, the numbers are buried in quarterly schedules. Our page surfaces those details in seconds.
Stock Titan’s AI reads each Xcel Brands quarterly earnings report 10-Q filing, the latest Xcel Brands 8-K material events explained, and every Xcel Brands proxy statement executive compensation. It then delivers plain-English highlights—no accounting glossary required. Need real-time alerts? The moment the company files Xcel Brands Form 4 insider transactions real-time, you’ll know whether executives increased or trimmed their stakes.
Here’s what you can do next:
- Compare segment margins without scrolling through 200 pages�understanding Xcel Brands SEC documents with AI.
- Monitor Xcel Brands insider trading Form 4 transactions before key product launches.
- Download AI-tagged exhibits for rapid Xcel Brands earnings report filing analysis.
Every document from 10-K to 20-F is updated the instant it hits EDGAR, so you never miss a disclosure. Stop sifting through PDFs; start using insights that matter.
Form 4 filed 08/01/2025 details insider activity at CCC Intelligent Solutions Holdings (CCCS). Executive Vice President & Chief Product and Technology Officer John P. Goodson vested previously granted restricted stock units (RSUs) on 07/30/2025.
- 21,875 common shares acquired at $0 (Code M) through automatic RSU conversion.
- 9,560 shares sold at $9.78 (Code F) to cover tax-withholding obligations.
Net result: +12,315 shares, lifting Goodson’s direct ownership to 200,009 shares. All shares from the 07/30/2021 four-year RSU grant are now settled; no derivative securities remain.
The transactions are routine, reflect no open-market purchase or discretionary sale, and modestly increase insider equity exposure, offering a neutral-to-slightly-positive alignment signal for shareholders.
Uber Technologies, Inc. (UBER) filed a Form 4 indicating that director John A. Thain acquired 278 restricted stock units (RSUs) on 07/10/2025 under the company’s RSU Conversion and Deferral Program for Directors. The RSUs were 100% vested at grant and will settle on a one-for-one basis in cash or common stock, at the company’s election, on 07/16/2025. Following the transaction, Thain beneficially owns 278 derivative securities directly. No open-market purchase or sale of Uber common stock occurred, and Table I (non-derivative securities) shows no changes.
On July 1, 2025, Sempra (SRE) director Michael N. Mears reported the acquisition of 164.09 phantom shares of Sempra common stock, according to a Form 4 filed on July 2, 2025. The phantom shares, issued as routine director compensation, convert into common stock on a 1-for-1 basis and are immediately exercisable. The reported price was $76.18 per phantom share.
After the grant, Mears beneficially owns 19,924.06 phantom shares, including 1,863.44 unvested restricted phantom shares that are subject to forfeiture if his board service ends for reasons other than death, disability or removal without cause. No shares were sold, and ownership remains direct.
The transaction is small relative to Sempra’s share count and appears to be a standard equity-based compensation event, implying minimal impact on insider sentiment or the company’s capital structure.
Form 4 filing for Xcel Brands, Inc. (XELB) discloses that Executive Vice President, Treasurer and Secretary Seth Burroughs received 6,273 shares of common stock on 06/30/2025 at an indicated price of $1.81 per share. The shares were issued by the company as compensation "in lieu of cash salary" under his employment agreement. To cover associated withholding taxes, Burroughs immediately surrendered 3,497 shares (transaction code “F�), also valued at $1.81. After the net addition of 2,776 shares, his direct beneficial ownership stands at 59,585 shares. No derivative securities transactions were reported. While the transaction modestly increases insider alignment with shareholders, the overall share count involved is immaterial to XELB’s total float, suggesting limited market impact.
Molina Healthcare (MOH) � Form 4 insider filing: Director Richard C. Zoretic received 180 shares of common stock on 01 July 2025 under the company’s 2025 Equity Incentive Plan. The quarterly grant is part of an annual equity award valued at $220,000; one-quarter ($55,000) is issued each quarter using the period’s closing price. At a closing price of $306.29, the quarterly amount translated into 180 shares. Following the transaction, Zoretic, through his revocable living trust, beneficially owns 7,345 shares of MOH. No derivative securities were involved, and the shares are held indirectly by the trust. This routine, compensation-related issuance modestly increases insider ownership and does not materially affect the company’s share count or capital structure.
On 17 June 2025, Xcel Brands, Inc. (NASDAQ: XELB) convened a Special Meeting where shareholders voted on two critical corporate actions. A quorum of 1,637,039 shares (�68.6% of the 2,386,325 outstanding) was present.
1. Warrant Exercise Proposal. Shareholders approved, under Nasdaq Rule 5635, the issuance of common stock exceeding 19.99% of outstanding shares upon exercise of refinancing-related warrants. The motion passed with 1,020,922 votes for, 5,503 against, 540 abstentions and 610,074 broker non-votes. The approval removes a regulatory barrier and allows the company to complete its April 21, 2025 refinancing terms.
2. Reverse Stock Split Proposal. Investors authorised the Board, at its discretion, to execute a reverse split between 1-for-2 and 1-for-5 any time before 25 March 2026. This measure passed decisively with 1,613,691 votes for, 23,019 against and 329 abstentions. The flexibility could help Xcel maintain Nasdaq listing standards by boosting its per-share price.
No additional matters required a vote. Collectively, the approvals provide management with enhanced capital-raising and compliance tools, though they introduce potential dilution and share-count reduction depending on future execution.
FAQ
What is the current stock price of Xcel Brands (XELB)?
What is the market cap of Xcel Brands (XELB)?
What is the core business of Xcel Brands?
How does Xcel Brands generate revenue?
What types of products does Xcel Brands offer?
How does Xcel Brands differentiate itself in the market?
What is the significance of the omnichannel strategy for the company?
How does the company maintain quality across its brands?
How does Xcel Brands compare to its competitors?
What role does design play in Xcel Brands' business model?
